Suppression of T Cell Autophagy Results in Decreased Viability and Function of T Cells Through Accelerated Apoptosis in a Murine Sepsis Model
Overview
Emergency Medicine
Authors
Affiliations
Objective: While type 1 programmed cell death (apoptosis) of T cells leads to immunosuppression in sepsis, a crosstalk between apoptosis and autophagy (type 2 programmed cell death) has not been shown. The aim of this study is to elucidate the details of the interaction between autophagy and immunosuppression.
Design: Laboratory investigation in the murine sepsis model.
Setting: University laboratory.
Subjects: Six- to 8-week-old male mice.
Interventions: We investigated the kinetics of autophagy in T cells from spleen in a cecal ligation and puncture model with green fluorescent protein-microtubule-associated protein light chain 3 transgenic mice. We analyzed apoptosis, mitochondrial homeostasis and cytokine production in T cells, and survival rate after cecal ligation and puncture using T cell-specific autophagy-deficient mice.
Measurements And Main Results: We observed an increase of autophagosomes, which was assessed by flow cytometry. However, an autophagy process in CD4 T cells during sepsis was insufficient including the accumulation of p62. On the other hand, a blockade of autophagy accelerated T cell apoptosis compared with the control mice, augmenting the gene expression of Bcl-2-like 11 and programmed cell death 1. Furthermore, mitochondrial accumulation in T cells occurred via a blockade of autophagy during sepsis. In addition, interleukin-10 production in CD4 T cells from the cecal ligation and puncture-operated knockout mice was markedly increased. Consequently, deficiency of autophagy in T cells significantly decreased the survival rate in the murine sepsis model.
Conclusions: We demonstrated that blocking autophagy accelerated apoptosis and increased mortality in concordance with the insufficient autophagy process in CD4 T cells in the murine sepsis model, suggesting that T cell autophagy plays a protective role against apoptosis and immunosuppression in sepsis.
Guo N, Xia Y, He N, Zhang L, Liu J Inflammation. 2025; .
PMID: 39994091 DOI: 10.1007/s10753-025-02265-w.
Islam M, Watanabe E, Salma U, Ozaki M, Irahara T, Tanabe S Front Immunol. 2024; 15:1493214.
PMID: 39720718 PMC: 11666431. DOI: 10.3389/fimmu.2024.1493214.
The impact of ulinastatin on lymphocyte apoptosis and autophagy in sepsis patients.
Zhang D, Song J, Zhan J, Wang Y, Deng J, Deng Y Sci Rep. 2024; 14(1):28791.
PMID: 39567616 PMC: 11579385. DOI: 10.1038/s41598-024-79878-y.
Lymphopenia in sepsis: a narrative review.
Wang Z, Zhang W, Chen L, Lu X, Tu Y Crit Care. 2024; 28(1):315.
PMID: 39304908 PMC: 11414153. DOI: 10.1186/s13054-024-05099-4.
Coman O, Grigorescu B, Hutanu A, Bacarea A, Vasiesiu A, Fodor R Medicina (Kaunas). 2024; 60(7.
PMID: 39064603 PMC: 11278887. DOI: 10.3390/medicina60071174.